4.3 Article

Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Management of urinary incontinence in postmenopausal women: An EMAS clinical guide

Eleonora Russo et al.

Summary: Urinary incontinence and other lower urinary tract symptoms increase after menopause, affecting 38% to 55% of women over 60 years old. The aim of this clinical guide is to provide an evidence-based approach to managing urinary incontinence in postmenopausal women. Healthcare professionals should prioritize urinary incontinence, develop appropriate diagnostic skills, and consider a wide range of treatment options including lifestyle modifications, pelvic floor exercises, and pharmacological interventions.

MATURITAS (2021)

Review Urology & Nephrology

A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment

Benoit Peyronnet et al.

EUROPEAN UROLOGY (2019)

Article Obstetrics & Gynecology

Genitourinary Syndrome of Menopause

Jan L. Shifren

CLINICAL OBSTETRICS AND GYNECOLOGY (2018)

Article Endocrinology & Metabolism

Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?

Michele Carlo Schiavi et al.

GYNECOLOGICAL ENDOCRINOLOGY (2018)

Article Public, Environmental & Occupational Health

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials

James A. Simon et al.

JOURNAL OF WOMENS HEALTH (2018)

Review Endocrinology & Metabolism

Symptoms of menopause - global prevalence, physiology and implications

Patrizia Monteleone et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Review Obstetrics & Gynecology

The human urinary microbiome and how it relates to urogynecology

Jenifer Schneeweiss et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2016)

Article Urology & Nephrology

Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014

Ann T. Hanna-Mitchell et al.

NEUROUROLOGY AND URODYNAMICS (2016)

Review Medicine, General & Internal

Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies

F. Bunn et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)

Article Urology & Nephrology

Oestrogens and Overactive Bladder

Dudley Robinson et al.

NEUROUROLOGY AND URODYNAMICS (2014)

Review Obstetrics & Gynecology

Vaginal Estrogen for Genitourinary Syndrome of Menopause A Systematic Review

David D. Rahn et al.

OBSTETRICS AND GYNECOLOGY (2014)

Article Urology & Nephrology

Urge Perception Index of Bladder Hypersensitivity

Atsuko Fujihara et al.

JOURNAL OF UROLOGY (2013)

Review Clinical Neurology

Antimuscarinics for treatment of overactive bladder

KE Andersson

LANCET NEUROLOGY (2004)

Review Obstetrics & Gynecology

The role of estrogen supplementation in lower urinary tract dysfunction

A Hextall et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2001)